Citius Pharmaceuticals, Inc. (CTXR)

CIK 1506251 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Citius Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 21, 20268-K0001213900-26-092604
Aug 14, 20268-K0001213900-26-090181
Aug 14, 202610-Q0001213900-26-090185
Aug 14, 2026SCHEDULE 13G/A0001649553-26-000102
Aug 5, 20268-K0001213900-26-085432
Jun 4, 2026SCHEDULE 13D/A0001213900-26-065310
Jun 2, 2026EFFECT9999999995-26-001857
Jun 1, 20268-K0001213900-26-063531
May 22, 2026S-30001213900-26-060644
May 15, 202610-Q0001213900-26-057842
May 15, 20268-K0001213900-26-057876
May 8, 20268-K0001213900-26-053916
Apr 29, 20268-K0001213900-26-049338
Apr 24, 20268-K0001213900-26-047599
Apr 24, 2026424B50001213900-26-047296
Apr 6, 20268-K0001213900-26-040474
Mar 31, 20268-K0001213900-26-037524
Mar 10, 20268-K0001213900-26-025459
Mar 4, 20268-K0001213900-26-023439
Feb 24, 2026ARS0001213900-26-019569
Feb 24, 2026DEF 14A0001213900-26-019566
Feb 24, 2026DEFA14A0001213900-26-019568
Feb 17, 2026SCHEDULE 13G/A0001649553-26-000024
Feb 13, 202610-Q0001213900-26-015878
Feb 13, 20268-K0001213900-26-015895